Deutsche Bank
FTH

Deutsche Bank’s Faeth Therapeutics FTH Stock Holding History

Deutsche Bank’s Portfolio FTH Stock Details FTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-567
Closed -$26K – 4307
2022
Q1 		$26K Sell
567
-67
-11% -$5.33K ﹤0.01% 4008
2021
Q4 		$74K Buy
634
+33
+5% +$4.93K ﹤0.01% 3829
2021
Q3 		$126K Buy
601
+368
+158% +$67K ﹤0.01% 3805
2021
Q2 		$45K Sell
233
-639
-73% -$158K ﹤0.01% 4329
2021
Q1 		$254K Buy
+872
New +$292K ﹤0.01% 3506

Other funds holding FTH

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Deutsche Bank's FTH Position: Q2 2022 in Review

Deutsche Bank sold out of Faeth Therapeutics (FTH) in Q2 2022, closing a stake of 567 shares — an estimated $26K sold.

Deutsche Bank first reported a position in FTH in Q1 2021 and held it in 5 quarters. The position peaked at $254K in Q1 2021. 39 funds tracked by Wall St. Rank hold FTH as of Q2 2022.

  • Deutsche Bank reported no remaining Faeth Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Deutsche Bank sold 567 Faeth Therapeutics shares in Q2 2022, an estimated $26K.
  • Deutsche Bank first reported a position in Faeth Therapeutics in Q1 2021 and held it in 5 quarters.
  • Deutsche Bank's Faeth Therapeutics position peaked at $254K in Q1 2021.
  • 39 funds tracked by Wall St. Rank held Faeth Therapeutics as of Q2 2022.

Based on Deutsche Bank's 13F filing for Q2 2022, filed 11 Aug 2022.